‹ All stocks
CG Oncology, Inc. Common stock
CGON · NASDAQ · Healthcare
$74.06
▼ $10.72 (-12.64%)
Day range
$74.00 – $83.97
Year range
$37.01 – $101.70
Open
$82.50
Previous close
$84.78
Market cap
$6.61B
Volume (24h)
$474.1K
Volume (52w)
$35.11M
Performance
7D
▲ 1.95%
1M
▲ 23.52%
3M
▼ -8.21%
6M
▲ 14.66%
1Y
▲ 79.54%
YTD
▲ 77.22%
3Y
▲ 99.25%
5Y
▲ 99.25%
All-time
▲ 99.25%
Key statistics
P/E ratio
-26.83
EPS (TTM)
$-2.76
Dividend yield
—
Dividend (TTM)
—
Payout ratio
—
Shares outstanding
89.3M
About CG Oncology, Inc. Common stock
CG Oncology Inc. is a biotechnology company in the clinical development stage, committed to advancing and bringing to market an innovative, bladder-sparing core treatment for individuals diagnosed with bladder cancer. Their principal drug candidate, cretostimogene, is presently undergoing clinical evaluation. Its initial focus is on providing a therapeutic option for patients suffering from high-risk Non-Muscle Invasive Bladder Cancer who have not responded to Bacillus Calmette Guerin (BCG) therapy, which represents the established standard of care for this particular severe form of NMIBC.
Visit websiteCountry: United States of America
More in Healthcare
LLY Eli Lilly and Company |
$1405.83 | -1.81% |
JNJ Johnson & Johnson |
$278.83 | -1.32% |
ABBV AbbVie |
$292.60 | -0.66% |
MRK Merck & Co. |
$143.45 | -0.70% |
UNH UnitedHealth Group Incorp… |
$392.83 | -4.66% |